123I-iodometomidate

DB13021InvestigationalSmall molecule

123I-iodometomidate is under investigation in clinical trial NCT00454103 (Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy).

Chemical structure of 123I-iodometomidate
Mechanism
Curator reviewed
Formula / weight
C13H13IN2O2 · 356.163 g/mol (avg)
Also known as
123 I Iodometomidate

Resolves to

Compound
UNIIU21CVV13SVCAS813466-05-6ChEMBLCHEMBL260402PubChem11660398
Structure
InChIKeyKECBLXVYTIVCTG-SECBINFHSA-NSMILESCOC(=O)C1=CN=CN1[C@H](C)C1=CC=C(I)C=C1
Targets
P15538CYP11B1P19099CYP11B2

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with 123I-iodometomidate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In